|
US5300645A
(en)
|
1993-04-14 |
1994-04-05 |
Eli Lilly And Company |
Tetrahydro-pyrido-indole
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AU2001257571A1
(en)
|
2000-05-10 |
2001-11-20 |
Icos Corporation |
Phosphatidyl inositol 3-kinase delta binding partner
|
|
DE10043667A1
(de)
|
2000-09-05 |
2002-03-14 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline
|
|
EP2070921A1
(en)
|
2000-11-07 |
2009-06-17 |
Novartis Ag |
Indolylmaleimide derivatives as protein kinase c inhibitors
|
|
DE60217322T2
(de)
|
2001-04-27 |
2007-10-04 |
Zenyaku Kogyo K.K. |
Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
|
|
TW200918046A
(en)
|
2002-04-03 |
2009-05-01 |
Novartis Ag |
Indolylmaleimide derivatives
|
|
CA2506432A1
(en)
|
2002-12-09 |
2004-06-24 |
Robert A. Kirken |
Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
|
|
NZ540729A
(en)
|
2002-12-27 |
2008-03-28 |
Angeletti P Ist Richerche Bio |
Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
|
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
DK1704145T3
(da)
|
2004-01-12 |
2012-09-24 |
Ym Biosciences Australia Pty |
Selektive kinaseinhibitorer
|
|
CA2553969A1
(en)
|
2004-01-23 |
2005-08-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
WO2005086814A2
(en)
*
|
2004-03-09 |
2005-09-22 |
The Uab Research Foundation |
Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3)
|
|
CA2566436C
(en)
|
2004-05-13 |
2011-05-10 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
SI1761528T1
(sl)
|
2004-06-11 |
2008-06-30 |
Japan Tobacco Inc |
5-amino-2,4,7-triokso-3,4,7,8-tetrahidro-2H-pirido(2,3-D)pirimidinski derivati in sorodne spojine za zdravljenje raka
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
KR20060079121A
(ko)
|
2004-12-31 |
2006-07-05 |
에스케이케미칼주식회사 |
당뇨 및 비만 치료예방에 유효한 퀴나졸린 유도체
|
|
MX2007013595A
(es)
|
2005-05-04 |
2008-01-24 |
Renovis Inc |
Compuestos heterociclicos fusionados y composiciones y usos de estos.
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
US8071597B2
(en)
|
2005-08-26 |
2011-12-06 |
Merck Serono Sa |
Pyrazine compounds and uses as PI3K inhibitors
|
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
KR20080089416A
(ko)
|
2005-12-21 |
2008-10-06 |
페인셉터 파마 코포레이션 |
개폐 이온 통로를 조절하기 위한 조성물 및 방법
|
|
GB0612630D0
(en)
|
2006-06-26 |
2006-08-02 |
Novartis Ag |
Organic compounds
|
|
WO2008009077A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
|
RU2009106722A
(ru)
*
|
2006-07-28 |
2010-09-10 |
Новартис АГ (CH) |
2,4-замещенные хиназолины в качестве ингибиторов липидной киназы
|
|
EP1891958A1
(en)
*
|
2006-08-03 |
2008-02-27 |
Universite Pierre Et Marie Curie (Paris Vi) |
Rho/Rock/PI3/Akt kinase inhibitors for the treatment of diseases associated with protozoan parasites.
|
|
KR20090087027A
(ko)
|
2006-11-13 |
2009-08-14 |
일라이 릴리 앤드 캄파니 |
염증 질환 및 암의 치료를 위한 티에노피리미디논
|
|
EP2139882B1
(en)
|
2007-03-23 |
2013-12-25 |
Amgen Inc. |
3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
|
|
DK2137186T3
(en)
|
2007-03-23 |
2016-04-18 |
Amgen Inc |
Heterocyclic compounds and their uses
|
|
EP2132207A2
(en)
|
2007-03-23 |
2009-12-16 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
EP2136639B1
(en)
|
2007-04-02 |
2016-03-09 |
Evotec AG |
Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
|
|
JP2010523639A
(ja)
|
2007-04-12 |
2010-07-15 |
エフ．ホフマン−ラ ロシュ アーゲー |
医薬化合物
|
|
EP2146981A1
(en)
|
2007-04-12 |
2010-01-27 |
F. Hoffmann-Roche AG |
Pharmaceutical compounds
|
|
GB0707087D0
(en)
|
2007-04-12 |
2007-05-23 |
Piramed Ltd |
Pharmaceutical compounds
|
|
PT2139334E
(pt)
|
2007-04-17 |
2013-10-02 |
Evotec Ag |
Compostos heterocíclicos fusionados de 2-cianofenilo, e composições e utilizações dos mesmos
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
WO2008150827A1
(en)
|
2007-05-29 |
2008-12-11 |
Smithkline Beecham Corporation |
Naphthyridine, derivatives as p13 kinase inhibitors
|
|
US7893060B2
(en)
|
2007-06-12 |
2011-02-22 |
F. Hoffmann-La Roche Ag |
Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
|
|
WO2008152394A1
(en)
|
2007-06-12 |
2008-12-18 |
F.Hoffmann-La Roche Ag |
Pharmaceutical compounds
|
|
WO2008152387A1
(en)
|
2007-06-12 |
2008-12-18 |
F.Hoffmann-La Roche Ag |
Quinazoline derivatives as pi3 kinase inhibitors
|
|
UY31137A1
(es)
*
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
Derivados de quinazolina como inhibidores de la pi3 quinasa
|
|
RU2341527C1
(ru)
|
2007-07-17 |
2008-12-20 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ
|
|
TW200908984A
(en)
|
2007-08-07 |
2009-03-01 |
Piramal Life Sciences Ltd |
Pyridyl derivatives, their preparation and use
|
|
WO2009036768A2
(en)
|
2007-09-19 |
2009-03-26 |
H. Lundbeck A/S |
Diagnosing potential weight gain in a subject
|
|
GB2467670B
(en)
|
2007-10-04 |
2012-08-01 |
Intellikine Inc |
Chemical entities and therapeutic uses thereof
|
|
US20100298289A1
(en)
|
2007-10-09 |
2010-11-25 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
|
WO2009058361A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Dynavax Technologies Corp. |
Inhibition of type i ifn production
|
|
CN101952292A
(zh)
|
2007-11-13 |
2011-01-19 |
艾科斯有限公司 |
人磷脂酰肌醇3-激酶δ的抑制剂
|
|
MX2010007419A
(es)
|
2008-01-04 |
2010-11-12 |
Intellikine Inc |
Ciertas entidades quimicas, composiciones y metodos.
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
JP2011515462A
(ja)
|
2008-03-27 |
2011-05-19 |
アウククランド ウニセルビセス リミテッド |
置換されたピリミジン、及びトリアジン、並びに癌療法におけるこれらの使用
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
WO2009147189A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
ES2383246T3
(es)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
ES2491522T3
(es)
|
2008-06-19 |
2014-09-08 |
Millennium Pharmaceuticals, Inc. |
Derivados de tiofeno o tiazol y su uso como inhibidores de PI3K
|
|
US8513221B2
(en)
|
2008-07-07 |
2013-08-20 |
Xcovery Holding, LLC |
PI3K isoform selective inhibitors
|
|
BRPI0915231A2
(pt)
|
2008-07-08 |
2018-06-12 |
Intellikine Inc |
compostos inibidores de quinase e métodos de uso
|
|
BRPI0919816A2
(pt)
*
|
2008-09-26 |
2019-09-24 |
Eisai R&D Man Co Ltd |
uso compostos benzoxazólicos no tratamento de malária
|
|
CA2738429C
(en)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
KR20160091440A
(ko)
|
2008-11-13 |
2016-08-02 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
WO2010059593A1
(en)
|
2008-11-18 |
2010-05-27 |
Intellikine, Inc. |
Methods and compositions for treatment of ophthalmic conditions
|
|
WO2010065923A2
(en)
|
2008-12-04 |
2010-06-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
BRPI1012333A2
(pt)
|
2009-03-24 |
2016-03-29 |
Gilead Calistoga Llc |
atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
|
|
SG174483A1
(en)
|
2009-03-24 |
2011-10-28 |
Univ Singapore |
Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
|
|
WO2010120991A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine compounds, their use as mtor, pi3, and hsmg-1 kinase inhibitors, and their syntheses
|
|
AP2011005956A0
(en)
|
2009-04-20 |
2011-10-31 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors.
|
|
LT2899191T
(lt)
|
2009-04-30 |
2017-10-25 |
Glaxo Group Limited |
Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai
|
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン， エルエルシー |
複素環式化合物およびその使用
|
|
BRPI1009022A2
(pt)
|
2009-05-27 |
2016-03-08 |
Hoffmann La Roche |
"composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
|
|
US8158625B2
(en)
|
2009-05-27 |
2012-04-17 |
Genentech, Inc. |
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
|
|
AU2010265971B2
(en)
|
2009-06-25 |
2014-08-14 |
Amgen Inc. |
Heterocyclic compounds and their uses as inhibitors of PI3 K activity
|
|
CN102625799A
(zh)
|
2009-06-25 |
2012-08-01 |
安姆根有限公司 |
杂环化合物及其用途
|
|
CA2765817A1
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
4h-pyrido[1,2-a]pyrimidin-4-one derivatives as pi3k inhibitors
|
|
SG176986A1
(en)
|
2009-06-25 |
2012-02-28 |
Amgen Inc |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
KR101763656B1
(ko)
|
2009-06-29 |
2017-08-01 |
인사이트 홀딩스 코포레이션 |
Ｐｉ3ｋ 저해물질로서의 피리미디논
|
|
HUE034503T2
(en)
|
2009-07-02 |
2018-02-28 |
Sanofi Sa |
2,3-Dihydro-1-imidazo [1,2-a] pyrimidin-5-one derivatives, their preparation process and their use in medicine
|
|
CN102482286B
(zh)
|
2009-07-02 |
2015-07-15 |
赛诺菲 |
新型1,2,3,4-四氢嘧啶并{1,2-a}嘧啶-6-酮衍生物、其制备以及其医药用途
|
|
CA2768843A1
(en)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Treatment of liver disorders with pi3k inhibitors
|
|
MX2012002059A
(es)
|
2009-08-20 |
2012-04-19 |
Karus Therapeutics Ltd |
Compestos heterociclicos triciclicos como inhibidores de fosfoionositida 3-quinasa.
|
|
JP2013505965A
(ja)
|
2009-09-29 |
2013-02-21 |
エックスカバリー ホールディング カンパニー エルエルシー |
Ｐｉ３ｋ（デルタ）選択的阻害剤
|
|
GB0918249D0
(en)
|
2009-10-19 |
2009-12-02 |
Respivert Ltd |
Compounds
|
|
NZ599830A
(en)
|
2009-11-05 |
2014-08-29 |
Rhizen Pharmaceuticals Sa |
Novel kinase modulators
|
|
US8741932B2
(en)
|
2009-11-06 |
2014-06-03 |
Piramal Enterprises Limited |
Imidazopyridine derivatives
|
|
EA201290305A1
(ru)
|
2009-11-13 |
2012-12-28 |
Мерк Сероно С.А. |
Производные трициклического пиразоламина
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
JP2013512880A
(ja)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
MX2012006953A
(es)
|
2009-12-18 |
2012-10-09 |
Amgen Inc |
Compuestos heterociclicos y sus usos.
|
|
TW201130842A
(en)
|
2009-12-18 |
2011-09-16 |
Incyte Corp |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
EP2539337A1
(en)
|
2010-02-22 |
2013-01-02 |
F. Hoffmann-La Roche AG |
Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
GB201007347D0
(en)
|
2010-04-30 |
2010-06-16 |
Karus Therapeutics Ltd |
Compounds
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
UA112517C2
(uk)
*
|
2010-07-06 |
2016-09-26 |
Новартіс Аг |
Тетрагідропіридопіримідинові похідні
|
|
ES2536780T3
(es)
|
2010-07-14 |
2015-05-28 |
F. Hoffmann-La Roche Ag |
Compuestos de purina selectivos para I3 p110 delta, y métodos de uso
|
|
CA2812091C
(en)
|
2010-09-14 |
2020-03-24 |
Exelixis, Inc. |
Inhibitors of pi3k-delta and methods of their use and manufacture
|
|
EP2616442B8
(en)
|
2010-09-14 |
2018-10-17 |
Exelixis, Inc. |
Inhibitors of pi3k-delta and methods of their use and manufacture
|
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
US9090628B2
(en)
|
2011-03-21 |
2015-07-28 |
Genentech, Inc. |
Benzoxazepin compounds selective for PI3K P110 delta and methods of use
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
AU2012236722A1
(en)
|
2011-03-28 |
2013-10-17 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
UY34013A
(es)
|
2011-04-13 |
2012-11-30 |
Astrazeneca Ab |
?compuestos de cromenona con actividad anti-tumoral?.
|
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
|
CN103987699A
(zh)
*
|
2011-10-21 |
2014-08-13 |
诺华股份有限公司 |
作为pi3k调节剂的喹唑啉衍生物
|
|
EP2790705B1
(en)
|
2011-12-15 |
2017-12-06 |
Novartis AG |
Use of inhibitors of the activity or function of pi3k
|